tiprankstipranks
AnaptysBio Inc (ANAB)
NASDAQ:ANAB
Holding ANAB?
Track your performance easily

AnaptysBio (ANAB) Financial Statements

350 Followers

AnaptysBio Financial Overview

AnaptysBio's market cap is currently ―. The company's EPS TTM is $-6.069; its P/E ratio is -3.62; AnaptysBio is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-1.55. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 30.02M$ 10.97M$ 7.18M$ 9.01M$ 3.32M
Gross Profit$ 30.02M$ 10.97M$ 7.18M$ 9.01M$ 3.32M
EBIT$ -32.85M$ -46.65M$ -37.62M$ -37.26M$ -37.31M
EBITDA$ -32.26M$ -46.06M$ -37.01M$ -36.65M$ -36.72M
Net Income Common Stockholders$ -32.85M$ -46.66M$ -43.94M$ -42.21M$ -37.31M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 430.12M$ 350.80M$ 354.67M$ 390.90M$ 413.05M
Total Assets$ 493.42M$ 427.38M$ 405.83M$ 452.39M$ 487.33M
Total Debt$ 16.49M$ 16.95M$ 17.39M$ 17.81M$ 18.23M
Net Debt$ -413.62M$ -333.86M$ -337.28M$ -373.09M$ -394.81M
Total Liabilities$ 409.05M$ 417.50M$ 358.06M$ 364.29M$ 366.94M
Stockholders Equity$ 84.37M$ 9.88M$ 47.78M$ 88.10M$ 120.38M
Cash Flow-
Free Cash Flow$ -10.13M$ -21.36M$ -37.28M$ -34.63M$ -36.64M
Operating Cash Flow$ -10.09M$ -21.32M$ -37.25M$ -34.35M$ -36.47M
Investing Cash Flow$ 58.62M$ -2.44M$ 68.62M$ 49.18M$ 30.64M
Financing Cash Flow$ 71.23M$ 41.89M$ -13.63M$ -5.16M$ -3.07M
Currency in USD

AnaptysBio Earnings and Revenue History

AnaptysBio Debt to Assets

AnaptysBio Cash Flow

AnaptysBio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis